ATHOS BIOINDUSTRIES

athos-bioindustries-logo

Athos Bioindustries is an industrial biotech company that harness microbial consortia from mining waste into minerals.

#SimilarOrganizations #Financial #Website #More

ATHOS BIOINDUSTRIES

Social Links:

Industry:
Biotechnology Chemical Manufacturing

Founded:
2024-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.athos.bio

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]


Similar Organizations

algasol-logo

Algasol

Algasol is a biotechnology company that provides algae biomass products for cosmetics, pharmaceutical, plastics, and biofuel industries.

biologic-company-logo

BioLogic Company

BioLogic Company is a biotechnology company that manufactures and supplies natural pest control products.

kalion-logo

Kalion

Kalion is a biotech company that manufactures high-purity chemicals for the pharmaceutical markets.

nature-plus-logo

Nature Plus

NPI is a biotechnology company that manufactures specialty formulations for industrial and consumer applications.

polestar-technologies-logo

Polestar Technologies

Polestar Technologies is a biotechnology company that offers optical monitoring and sensor products for industrial & commercial industries.

tex-biosciences-logo

Tex Biosciences

Tex Biosciences is an industrial biotech company that manufactures enzymes, probiotics, and other biotech products.

toyobo-usa-logo

Toyobo USA

Toyobo USA is a chemical company that provides functional polymers, industrial materials, and healthcare products.

Investors List

sosv_image

SOSV

SOSV investment in Seed Round - Athos Bioindustries

synbio-axlr8r_image

IndieBio

IndieBio investment in Seed Round - Athos Bioindustries

Official Site Inspections

http://www.athos.bio

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Athos Bioindustries"

Athos - IndieBio - #1 in Early Stage Biotech

Athos Bio is developing bio-mineralization technology that mitigates this waste, transforming it into a medium for permanent carbon storage and the recovery โ€ฆSee details»

Athos Bioindustries - Crunchbase Company Profile

When was the last funding round for Athos Bioindustries? Athos Bioindustries โ€ฆSee details»

Athos Bioindustries 2025 Company Profile: Valuation, โ€ฆ

Athos Bioindustries General Information Description. Developer of bio โ€ฆSee details»

Athos Therapeutics Inc. - BIO International Convention 2025

Athos is a clinical stage biotech pioneering the development of Artificial Intelligence-based, first-in-class precision therapeutics for patients with IBD (entering a Phase 2 in UC with ATH-063), โ€ฆSee details»

All Three Athos Co-Founders Named to Stanfordโ€™s List of the โ€ฆ

Oct 12, 2023 "It is a great honor to be included together with all the Athos co-founders in Stanford's prestigious list of the world's top 2% of scientists," said Dimitrios Iliopoulos, PhD, โ€ฆSee details»

Home - Athos Therapeutics

Athos Therapeutics Innovative Drug Discovery & Development Platform. Athos has developed a unique platform able to identify and develop novel drugs for โ€ฆSee details»

Athos - 2025 Company Profile, Funding & Competitors - Tracxn

Apr 27, 2025 Athos - Provider of solution to turn mining waste into industrial materials. Raised funding from 1 investor. Founded by Liz Muntean, Matthew LaRosa and 1 other in the year โ€ฆSee details»

Athos - SOSV

Athos.bio . Team Gabriel Villar. CEO. Matthew La Rosa. Chief Technology Officer ... Get In Touch with Athos. Please tell us a little bit about yourself and why โ€ฆSee details»

Athos - Products, Competitors, Financials, Employees, โ€ฆ

Athos was founded in 2024. Where is Athos's headquarters? Athos's headquarters is located at 7 Penn Plaza, New York. What is Athos's latest funding round? Athos's latest funding round is โ€ฆSee details»

Athos Bioindustries, Inc. - Drug pipelines, Patents, Clinical trials ...

Dec 11, 2024 Last update 02 Nov 2024. Athos Bioindustries, Inc. Private Company |See details»

Athos, an autoimmune and cancer biotech, is raising โ€ฆ

Feb 16, 2024 Athos Ther­a­peu­tics is rais­ing ... field has ex­pe­ri­enced a rush of ac­tiv­i­ty in the past year with big-name deals like Mer­ckโ€™s Prometheus โ€ฆSee details»

Athos Service GmbH - life-sciences-usa.com

BIO-Europe 2025 Vienna (Wien) BIO-Europe Spring 2026 Lisboa (Lisbon) ... BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) France โ€ฆSee details»

A Co-Founder of Athos Therapeutics, Dr. Michael E. Jung

May 1, 2025 LOS ANGELES, CA / ACCESS Newswire / April 30, 2025 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision โ€ฆSee details»

All Three Athos Co-Founders Named to Stanfordโ€™s ... - Athos โ€ฆ

Oct 12, 2023 The complementary expertise of the Athos co-founders has been a key factor in Athosโ€™s rapid development of its lead program (ATH-063) from concept to phase I clinical trial โ€ฆSee details»

Athos, an autoimmune and cancer biotech, is raising $35M for โ€ฆ

Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small โ€ฆSee details»

athosliving.com Reviews: Is this site a scam or legit?

Is athosliving.com legit? It's definitely questionable. If you plan to do business on this site, proceed with caution as it received a medium score on our chart. We put to work 53 powerful โ€ฆSee details»

BIO Announces Dedicated Focus on Human Health and โ€ฆ

1 day ago Washington, DC, May 28, 2025 โ€“ The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work โ€ฆSee details»

Media - Athos Therapeutics

Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory โ€ฆSee details»

ATH-293 - Drug Targets, Indications, Patents - Synapse

ATH-293, Initially developed by Athos Therapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Congenital ...See details»

Athos, an autoimmune and cancer biotech, is raising $35M for โ€ฆ

Feb 16, 2024 Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based precision small โ€ฆSee details»

linkstock.net © 2022. All rights reserved